What patients is Mobotinib suitable for and how much can it cost?
Mobocertinib (Mobocertinib, trade name: Exkivity) is a targeted therapy for locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations. The drug is indicated for adult patients with EGFR exon 20 insertion mutations whose disease has progressed during or after platinum-based chemotherapy. As a prescription drug, Mobotinib must be used under the guidance of a doctor. Patients must consult a professional doctor before taking the drug to ensure that the drug is suitable for their disease type and treatment needs.
In terms of price, the original drug of Mobotinib is relatively expensive, about tens of thousands of yuan per box, which has put financial pressure on many patients. However, with the introduction of generic drugs, this situation has improved significantly. In the Laotian market, the generic drug of Mobotinib produced by Lucius Pharmaceuticals and Daxiong Pharmaceutical is priced at more than 3,000 yuan. Compared with the original drug, this price undoubtedly reduces the huge financial burden for patients. In the Bangladeshi market, the generic drug of Mobotinib produced by Ziska Pharmaceuticals is priced at more than 2,000 yuan, which also reduces the cost of medication for patients.
It should be noted that the trade names and specifications of mobotinib produced by different manufacturers may be different. When purchasing, patients should carefully check drug information to ensure that the purchased drugs are consistent with official information. At the same time, there are certain risks in purchasing drugs overseas, and patients must be cautious when choosing purchasing channels. In order to ensure the quality and safety of medicines, be sure to choose formal and guaranteed channels to avoid purchasing fake and shoddy products.
In short, mobotinib provides a new treatment option for patients with non-small cell lung cancer carryingEGFR exon 20 insertion mutations, and the launch of generic drugs has greatly reduced the cost of medication for patients. However, during the drug purchase process, patients still need to remain vigilant to ensure the quality and safety of the drugs they purchase.
References:
https://www.drugs.com/search.php?searchterm=Exkivity+FDA
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)